ifosfamide Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Unknown (1)

Interventional (1)
Observational (1)

Grupo Espanol de Investigacion en Sarcomas (1)
Sun Yat-sen University (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadejection fraction

I am/have/hadadjuvant therapy

I am/have/hadmetastatic osteosarcoma

I am/have/hadresectable osteosarcoma

I am/have/hadlocalized disease

I am/have/hadhepatitis c

I am/have/hadtumor necrosis

I am/have/hadsubstance abuse

added new label for I am/have/had

more

I am looking for

I am looking forifosfamide

I am looking formonoclonal antibodies

I am looking foradriamycin

I am looking forcamrelizumab

I am looking forp-glycoprotein

I am looking forglycoprotein

I am looking forpsychotropic

I am looking formethotrexate

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Study objective is to compare the efficacy and safety of camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.

monoclonal antibodies

ifosfamide

camrelizumab

adriamycin

hepatitis c

0 views
19 Feb, 2024

For pediatric ages
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities

In some sites they will consider the non-administration of MTP-PE or the non-administration of high doses of ifosfamide. And, in some hospitals, they will consider administering MTP-PE to all patients.

ifosfamide

metastatic osteosarcoma

adriamycin

methotrexate

p-glycoprotein

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.